Iopamiro

Iopamidol, the active ingredient in Iopamiro, is a non‑ionic iodinated contrast media presented as an injectable solution for intraarterial, intraarticular, intrathecal use. It provides radiodensity for imaging studies such as angiography, arthrography, myelography and CT with contrast in adult and pediatric patients.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iopamiro, a non‑ionic iodinated contrast agent, is used in radiographic procedures that require enhanced X‑ray absorption.

Angiography: improves visualization of blood vessels during diagnostic and interventional procedures. Arthrography: enhances joint space imaging to assess cartilage and soft‑tissue structures. Myelography: provides contrast for spinal canal evaluation and nerve root visualization. CT imaging with contrast: increases lesion detection and organ delineation in computed tomography studies.

Iopamiro may cause a range of adverse reactions, from mild to severe, depending on patient sensitivity and administered dose.

Common Side Effects: - Warm sensation at injection site: transient feeling of heat. - Nausea: mild to moderate upset stomach. - Metallic taste: brief alteration of taste perception. - Flushing: mild skin reddening.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring emergency care. - Acute kidney injury: sudden decline in renal function after exposure. - Cardiovascular collapse: severe drop in blood pressure or cardiac arrest.

Before using Iopamiro, clinicians should consider several safety measures to minimize risk.

Assess renal function: evaluate baseline creatinine and eGFR. Review allergy history: check for prior reactions to iodine‑based contrast. Hydration: ensure adequate fluid intake before and after administration. Use lowest effective dose: limit iodine load to the minimum required for diagnostic quality. Monitor vital signs: observe patients during and after injection for any adverse reactions. Store at ambient temperature: keep in original container, protect from light and moisture.

Iopamiro can interact with certain medications, influencing safety or efficacy.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in patients with renal impairment. - Thyroid hormones: contrast may interfere with laboratory assessment. - ACE inhibitors: may increase likelihood of contrast‑induced nephropathy. - Loop diuretics: can exacerbate renal effects when combined with iodinated contrast.

Moderate Interactions (Monitor Closely): - NSAIDs: may heighten nephrotoxic potential. - Beta‑blockers: can mask tachycardia signs of an allergic reaction. - Calcium channel blockers: possible additive hypotensive effect.